Search Medical Condition
Please enter condition
Please choose location from dropdown

Zhongshan, China Clinical Trials

A listing of Zhongshan, China clinical trials actively recruiting patients volunteers.

RESULTS

Found (14) clinical trials

Efficacy and Safety of Sotagliflozin Versus Placebo in Chinese Patients With Type 2 Diabetes Mellitus Not Adequately Controlled by Metformin With or Without Sulfonylurea

Total study duration is up to 30 weeks, including a screening period consisting of a screening phase of up to 2 weeks and a 2-week single-blind placebo run-in phase, a 24-week double-blind treatment period, and a 2-week post-treatment follow-up visit period to collect safety information.

Phase

0.0 miles

Learn More »

Nasopharyngeal Carcinoma Screening in Zhongshan City

The research is to evaluate the effect of NPC screening, also as an extended study of Screening for Nasopharyngeal Carcinoma in High Risk Populations (NCT00941538). The program was conducted in Xiaolan and Minzhong towns of Zhongshan city in 2012. All participants will be tested for anti-EBV antibody by using serum ...

Phase N/A

0.32 miles

Learn More »

China Protection Trial of Glucose Metabolism by Pitavastatin in Patients With Prediabetes and Hypertension

Within the 12 months of the study procedure, the 3rd month is what we called the "check point". At this point, participants' plasma LDL-C will be measured whether it reached individual standard or not. If the results didn't meet the particular LDL-C standard, the participants would be adjusted the drug ...

Phase

0.32 miles

Learn More »

Study of the Efficacy Safety and Pharmacokinetics of BGB-290 in Subjects With Advanced Solid Tumors

This study is designed to evaluate the safety, tolerability, PK profile and treatment effect of BGB-290 (pamiparib) in Chinese advanced cancer subjects in phase I, and to evaluate the efficacy and safety of BGB-290 (pamiparib) in Chinese patients with advanced epithelial ovarian cancer (including fallopian cancer or primary peritoneal cancer), ...

Phase

1.42 miles

Learn More »